Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Inventory (2016 - 2025)

Surgery Partners' Inventory history spans 12 years, with the latest figure at $96.6 million for Q4 2025.

  • For Q4 2025, Inventory rose 9.28% year-over-year to $96.6 million; the TTM value through Dec 2025 reached $96.6 million, up 9.28%, while the annual FY2025 figure was $96.6 million, 9.28% up from the prior year.
  • Inventory for Q4 2025 was $96.6 million at Surgery Partners, up from $92.3 million in the prior quarter.
  • Across five years, Inventory topped out at $96.6 million in Q4 2025 and bottomed at $56.1 million in Q1 2021.
  • The 5-year median for Inventory is $71.6 million (2022), against an average of $74.0 million.
  • The largest annual shift saw Inventory increased 1.17% in 2023 before it grew 18.16% in 2024.
  • A 5-year view of Inventory shows it stood at $61.1 million in 2021, then rose by 16.86% to $71.4 million in 2022, then rose by 5.32% to $75.2 million in 2023, then grew by 17.55% to $88.4 million in 2024, then grew by 9.28% to $96.6 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Inventory are $96.6 million (Q4 2025), $92.3 million (Q3 2025), and $87.3 million (Q2 2025).